The South Australian Prostate Cancer Register has rejected the finding from an Italian study that Androgen Deprivation Therapy (ADT) reduces COVID-19 infections in high-risk male populations. With risks involved in ADT treatment, the South Australian Prostate Cancer Register believe that existing ADTs are not a viable treatment option for COVID-19.
COVID-19 and Androgen Deprivation Therapy